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A possible association between Friedreich’s ataxia (FA) and neoplastic development has been recognized. FA patients have low
frataxinlevelsandinsuﬃcientresponsetooxidativestress.Inthesepatientsﬁbroblastsarecharacterizedbyahighrateofmutations.
Herein, a case of a 39-year-old woman with FA tetraplegia, who was admitted in our department with intestinal obstruction due
to a huge uterine tumor,is described. An abdominalCT revealed a huge intra-abdominalmassoriginatingfrom the right cornu of
the uterus. Tumor excision and adhesionlysis were performed. The histological examination of the tumor revealed a leiomyoma.
FA patients seem to present with a variety of neoplasms uncommon for their young age. This is the ﬁrst report of a leiomyoma
originating from the genital system in a female patient with FA tetraplegia. Therefore it is important to identify neoplasms at an
early stage in patients with FA and start immediate therapy.
1.Introduction
Friedreich’s Ataxia (FA) is an autosomal recessive disease of
the cerebellum, spinal cord, and peripheral nerves described
byFriedreichin1863[1].Itischaracterized pathologicallyby
degeneration of the spinal and cerebellar reﬂexes and clini-
cally by ataxic gait, dysarthria, loss of reﬂexes, and heart dis-
ease [2–4]. Although incidences of coexisting tumors of the
connectivetissuehavebeenreported inthisgroupofpatients
andthequestionofacorrelationoftheconditionwithmalig-
nancies in general has been raised [3], a possible association
betweenneoplasiasoftheconnectivetissue(benignormalig-
nant) and FA has not been previously discussed. Herein,
we present a case of a 39-year-old patient with a history of
FA and a huge uterine leiomyoma, who was admitted with
symptoms of acute intestinal obstruction. This case illus-
trates the importance of reporting such cases and of further
investigation in this ﬁeld. Moreover, it stresses the clinicians’
attention in becoming more sensitive on early diagnosis and
treatment of such neoplasias in this group of patients.
2.Case Presentation
A39-year-oldwhitefemalepatientwasadmittedtotheemer-
gency department of our hospital with symptoms of acute
intestinal obstruction, ﬁrst noted 48 hours before (colicky
abdominal pain, vomiting, and abdominal distention). The
patient was tetraplegic due to Friedreich’s disease diagnosed
25years agoand was hospitalized permanentlyin acenterfor
chronic disorders.
Upon physical examination, a prominent abdominal
mass distorting her trunk shape was noted. In palpation, the
abdomen had considerable distension with diﬀuse tender-
ness and moderate rebound tenderness. Despite the disten-
sion in the upper abdomen, a huge tumor could easily be
palpated occupying mainly the lower abdomen.2 Case Reports in Medicine
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Figure 1: (a–c) MRI images indicating a huge mass occupying the greatest part of the abdominalcavity compressing the intestinal loops.
The neurological examination revealed good responsive-
ness of the patient, quadriplegia, loss of tendon reﬂexes,
and positive Babinski sign bilaterally. She was then referred
for cardiac evaluation, where mitral insuﬃciency and left
ventricular hypertrophy were found.
The white blood cell count was 18,100/μL with 79.1%
neutrophils, which was further elevated the second day; urea
was found 51mg/dL and γGT 54mU/mL. The rest of the
blood tests were normal.
The most possible diagnosis was intestinal obstruction
probably due to the tumor. An abdominal computed tomo-
graphy was performed, which revealed a huge intra-abdo-
minal mass originating most possibly from the right cornu
of the uterus (Figures 1(a), 1(b), 1(c)).
An emergency exploratory laparotomy followed with a
midline incision.
After the peritoneal cavity was opened an enormous
circumscribedmass measuring 29.5×22×12cmwasrevealed
displacing the bowel to the abdominal periphery. The mass
originated from the right cornu of the uterus. After lysis of
the adhesions between the tumor and the greater omentum,
the tumor was excised (Figure 2) and the right uterine cornu
was ligated with a nonabsorbable suture. Inspection of the
small intestine revealed a stenotic area in its central portion
due to an adhesion with the omentum. The adhesion was
taken down and careful hemostasis followed. Finally the
abdominal wound was closed in the ordinary fashion.
The tumor, as well as the peritoneal washings, was sent
for histological and cytological assessment, which did not
reveal any evidence of malignancy. Histological assessment
ofthe specimen revealeda uterine leiomyoma with increased
mitotic activity. The postoperative course was uneventful,
andthepatienthadnofurther complications.Atpresent,two
years after surgery the patient fares well and lives in a center
for chronic disorders.
3.Discussion
FA is an autosomal recessive spinocerebellar neurodegenera-
tivedisease with awide range ofclinicalsigns and symptoms,
Figure 2: The huge compact tumor after being removed from the
abdominal cavity.
the onset of which in the majority of the cases occurs during
adolescence. Although FA is a rare condition, it is the most
common hereditary ataxia. The disease results in a relatively
low life expectancy, and therefore the survival beyond the
forth decade is unusual [2].
The neurological ﬁndings of the disease include limb
andtruncalataxia,dysarthria, loss oflower-extremity tendon
reﬂexes, and progressive corticospinal tract disorder as well
as lossofvibratory and proprioceptivesensation. The disease
has also nonneurological manifestations such as kyphoscol-
iosis, pes cavus, diabetes mellitus with insulin resistance and
heart disease, atrial ﬁbrillation with resultant tachycardia,
and cardiomyopathy [3, 5].
FA is caused by a pronounced lack of fraxatin, a mito-
chondrial protein of not well-understood function [2]. The
underlying molecular defect leading to the clinical features
of FA is the mutation of the frataxin gene located in chro-
mosome 9q13. The result of this mutation is an expansion
of repeated GAA triplets in intron I, the length of which is
strongly associated with the severity of the clinical appear-
ance [6].Case Reports in Medicine 3
Frataxin is a mitochondrial protein found predominately
i nt h eb r a i n ,h e a r t ,a n dp a n c r e a s .A l t h o u g ht h em a i nf u n c -
tion of frataxin is still a matter of discussion [7], some evi-
dence suggests that this protein directs the intramitochon-
drial synthesis of Fe/S clusters [8–10] and is undoubtedly
involved in the control of oxidative metabolism by reinforc-
ing the ATP synthesis possibly due to a direct interaction
with the respiratory chain [11, 12]. Frataxin is overexpressed
in ﬁbroblasts. Moreover, disruption of the frataxin homo-
logue in yeast has been proven to increase sensitivity to
oxidants and promote oxidative damage to both nuclear
and mitochondrial DNA [13, 14]. Lack of hepatic frataxin
expression causes liver tumor growth in mice following
impaired mitochondrial function and increased ROS forma-
tion. Hence, frataxin might be considered a mitochondrial
tumor suppressor protein located upstream of established
stress kinases in mammals, such as p38 MAP kinase [15].
Moreover, Schulz et al. [16] have shown that induction of
oxidative metabolism by mitochondrial frataxin suppresses
malignant growth in vitro and in vivo, due to the fact that
mitochondrial iron detoxiﬁcation is a primary function of
frataxin. Frataxin seems to limit oxidative damage and pre-
serve cell longevity [17].
Fraxatin not only protects tumor cells against oxidative
stress and apoptosis but also acts as a tumor suppressor.
Fraxatin expression is upregulated in several tumor cell lines
in response to hypoxic stress, a condition often associated
with tumor progression. The ability of tumor cells to main-
tain a balance between adaptation to hypoxia and cell death
is mediated by hypoxia-inducible factors (HIFs), which
regulate the expression of hypoxia-responsive genes [18].
Therefore fraxatin upregulation in response to hypoxia
depends on HIF expression, and this modulates activation
of the tumor suppressor gene p53, while fraxatin dampens
oxidative stress. Overall fraxatin participates in the hypoxia-
induced stress response in tumors, and modulation of its
expression could have an important role in neoplastic cell
survival and tumor progression [18].
FA patients have low frataxin levels and insuﬃcient re-
sponse to oxidative stress [19]. In this subgroup of patients,
ﬁbroblasts are characterized by a particular sensitivity to
ionizing radiation and a high rate of mutations [20]. The
aforementioned facts could support a hypothesis of an
association between FA and tumor development, thus of the
connective tissue. We have presented a noteworthy case of a
39-year-oldfemalepatientwithhistoryofFriedreich’sdisease
and a uterine leiomyoma, indicating the coexistence of FA
and an early onset neoplasia of the connective tissue.
Recently, two enzymes involved in the tricarboxylic acid
(TCA) cycle, fumarate hydratase (FH), and succinate dehy-
drogenase (SDH), which also plays a role in oxidative phos-
phorylation, have been shown to be tumor suppressors.
Indeed germline mutations of FH predispose individuals
to the development of uterine or cutaneous leiomyomas,
whereas mutations in SDH cause hereditary paraganglio-
mas and pheochromocytomas [21]. On the other hand, FH
deﬁciency has been identiﬁed in a few cases of encephalomy-
opathy, whereas a generalized deﬁciency of iron-sulfur pro-
teins, including SDH, causes Friedreich ataxia [22]. These
observations may oﬀer strong evidence in the genetic asso-
ciation between FA and leiomyoma development.
Although tumor development is not a typical manifes-
tation of the disease, these patients seem to present with a
variety of neoplasms uncommon for their age. To the best
of our knowledge, six cases of neoplasias with FA have been
described in the literature, but none of them was associated
with leiomyoma. In summary, in 1986, Barr et al. [23]
presented the case of a small primary ganglioneuroblastoma
and FA. In 1996 Ackroyd et al. [24] reported the case of
two siblings with FA who both developed a signet ring cell
adenocarcinoma of the stomach stating the assumption of
the existence of unidentiﬁed aberrant gene. In 1999, De Pas
et al. [5] described a case of coexisting FA and lymphoblastic
lymphoma, while in 2001 the case of two sisters with FA and
breast cancer was added in world literature by Kidd et al.
[25]. The list of cases is further grown in 2004, when Shah
et al. [26] published an additional case of neuroﬁbromatosis
type I and FA similar to the one described in 1999 in a
Nigerian family [27].
Although the question of a possible association between
FA and malignancy in general was raised by Kidd and his
colleagues [24], it has not been clariﬁed yet. We support the
hypothesis of an association between FA and neoplasias of
the connective tissue (benign or malignant), although such
a causal relationship would be nearly impossible to demon-
strate statistically due to the low number of cases. This could
be explained by an underreporting of FA and such tumors
occurring together since the neoplasias of the connective
tissue are very common in the general population. We know,
for example, that leiomyoma is a very common condition in
the general population but we do not know how common it
is in patients with FA and if there is a statistically important
diﬀerence. Moreover, the patients with early onset of FA die
at a young age mostly because of cardiomyopathy and conse-
quentlytheydonotlivelongenoughtodevelopsuchtumors.
However, it is important to identify tumor development
at an early stage in patients with FA and start immediate
therapy; therefore the clinician should be sensitive enough
to detect them.
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